AUTHOR OF THIS BLOG

DR ANTHONY MELVIN CRASTO, WORLDDRUGTRACKER
Jul 222013
 

File:Lubiprostone.svg

 

Dr Reddy’s Laboratories Ltd new patent on

Preparation of lubiprostone

Jackson, Mark; Dahanukar, Vilas Hareshwar; Joseph, Suju Chuttippari; Eda, Vishnu Vardhana Verma Reddy; Ramdas, Sandip Khobare

US 20130184476, 18-JUL-2013

IN2011CH2389 13-JUL-2011 priority

NCT01674530, Phase 3

_____________________________________________________

general info in public domain

Lubiprostone (rINN, marketed under the trade name Amitiza) is a medicationused in the management of chronic idiopathic constipation and irritable bowel syndrome. It was approved by the U.S. Food and Drug Administration (FDA) for this purpose on 31 January 2006.

Lubiprostone is used for the treatment of chronic constipation of unknown cause in adults, as well as irritable bowel syndrome associated with constipation in women.

As of 20 July 2006, Lubiprostone has not been studied in children. There is current research underway to determine the efficacy in postoperative bowel dysfunction, and opioid-induced bowel dysfunction.

Synthesis:Sobrera, L. A.; Castaner, J. (2004). Drugs of the Future 29 (4): 336.

Lubiprostone.png

Lubiprostone received approval from the Food and Drug Administration on 29 April 2008 to treat irritable bowel syndrome withconstipation (IBS-C).

 

Share

  One Response to “Dr Reddy’s Laboratories Ltd-Patent-Preparation of lubiprostone”

  1. It’s hard to find your page in google. I found it on 16 spot, you should build quality backlinks ,
    it will help you to rank to google top 10. I know how to
    help you, just search in google – k2 seo tips and tricks

Sorry, the comment form is closed at this time.

Follow

Get every new post on this blog delivered to your Inbox.

Join other followers: